Laurence Reid

Insider Reports History

Entity
Individual
Location
300 Third Street, Cambridge, MA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laurence Reid:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 17K Nov 23, 2024 Direct
Decibel Therapeutics, Inc. President and Chief Executive Officer, Director Common Stock 0 $5.03 Sep 25, 2023 Direct
Decibel Therapeutics, Inc. President and Chief Executive Officer, Director Stock Option (right to buy) 0 Sep 25, 2023 Direct

Insider Reports Filed by Laurence Reid

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Nov 23, 2024 1 $0 4 Nov 26, 2024 Director
KALV KalVista Pharmaceuticals, Inc. Nov 23, 2024 0 $0 3 Nov 26, 2024 Director
DBTX Decibel Therapeutics, Inc. Sep 25, 2023 4 $0 4 Sep 25, 2023 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. Mar 16, 2023 2 $0 4 Mar 17, 2023 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. Feb 25, 2022 1 $0 4 Feb 28, 2022 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. Sep 15, 2021 1 $76.4K 4 Sep 17, 2021 President and Chief Executive, Director